Chemoinformaics analysis of Tricin-7-O-Alpha-L-Rhamnosyl-Hexoside
| Molecular Weight | 652.558 | nRot | 8 |
| Heavy Atom Molecular Weight | 620.302 | nRig | 31 |
| Exact Molecular Weight | 652.164 | nRing | 5 |
| Solubility: LogS | -3.317 | nHRing | 3 |
| Solubility: LogP | 0.199 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 78 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 46 | No. of Aromatic Carbocycles | 2 |
| nHetero | 17 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 17 | No. of Arom Bond | 17 |
| nHA | 16 | APOL | 83.4014 |
| nHD | 8 | BPOL | 45.9906 |
| QED | 0.145 |
| Synth | 4.811 |
| Natural Product Likeliness | 1.819 |
| NR-PPAR-gamma | 0.973 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.993 |
| HIA | 0.979 |
| CACO-2 | -6.568 |
| MDCK | 0.000104394 |
| BBB | 0.097 |
| PPB | 0.690969 |
| VDSS | 0.495 |
| FU | 0.304724 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.096 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.218 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.151 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.002 |
| CL | 1.014 |
| T12 | 0.546 |
| hERG | 0.009 |
| Ames | 0.194 |
| ROA | 0.025 |
| SkinSen | 0.012 |
| Carcinogencity | 0.173 |
| EI | 0.005 |
| Respiratory | 0.039 |
| NR-Aromatase | 0.843 |
| Antiviral | Yes |
| Prediction | 0.789335 |